The Melanoma Letter Fall 2014, Vol. 32, No. 3

Most experts and policy makers today agree that targeted screening of people at elevated risk for melanoma is valuable and worth the cost. It makes sense, since these individuals have the highest likelihood of developing the disease. In this issue of The Melanoma Letter, Drs. Crew, Tyagi, Miller and Cockburn provide an excellent, comprehensive review and analysis of current apps and their role in both public and professional skin cancer education and detection.